Compare Nutanix Inc (NTNX) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs BIO-TECHNE Corp — how do they compare? Nutanix Inc trades at $54 (market cap $14.90B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: Nutanix Inc is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals.
| NTNX | TECH | |
|---|---|---|
Market Cap | $14.90B | $11.16B |
Sector | Technology | Health |
52-Week High | $81.12 | $72.12 |
52-Week Low | $34.41 | $43.31 |
Enterprise Value | $14.41B | $11.24B |
Dividend Yield | — | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
